DNA topoisomerase I

Customs officer at the border between DNA and RNA worlds?

Jamal Tazi, Ferdinand Rossi, Emmanuel Labourier, Imed Gallouzi, Claude Brunel, Etienne Antoine

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

DNA topoisomerase I is required for the normal development of multicellular organisms, probably because it plays a role in controlling gene activity, in addition to its function in relieving tortional stress during DNA replication and transcription. The discovery of DNA topoisomerase I as a specific kinase that phosphorylates serine-arginine rich (SR) splicing factors may provide new insights into their precise function in regulating gene expression. It is clear that the splicing factors phosphorylated by DNA topoisomerase I can modulate gene expression by changing the splicing pattern of structural genes. Studies of the splicing mechanism suggest that the phosphorylation of serine residues of SR proteins contribute to their activity. As this phosphorylation can be accomplished by several kinases, it remains to be determined whether phosphorylation by DNA topoisomerase I protein kinase is the limiting step in regulating this process. The availability of specific inhibitors of DNA topoisomerase I, structurally related to the alkaloid camptothecin, have made it possible to address this question experimentally. These inhibitors, which hold great promise as antineoplastic drugs, lead to specific inhibition of SR protein phosphorylation in cultured cells. This observation will hopefully lead to improved understanding of the mechanism by which these drugs act at cellular level.

Original languageEnglish
Pages (from-to)786-800
Number of pages15
JournalJournal of Molecular Medicine
Volume75
Issue number11-12
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Type I DNA Topoisomerase
Phosphorylation
RNA
Serine
DNA
Arginine
Phosphotransferases
Topoisomerase I Inhibitors
Gene Expression
Camptothecin
DNA Replication
Alkaloids
Antineoplastic Agents
Protein Kinases
Genes
Cultured Cells
Proteins
Pharmaceutical Preparations

Keywords

  • Alternative splicing
  • DNA topoisomerase I
  • mRNA precursor
  • Nucleus
  • Protein kinase
  • Protein phosphorylation
  • Small nuclear Ribonucleoprotein
  • Splicing factors

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Genetics(clinical)

Cite this

Tazi, J., Rossi, F., Labourier, E., Gallouzi, I., Brunel, C., & Antoine, E. (1997). DNA topoisomerase I: Customs officer at the border between DNA and RNA worlds? Journal of Molecular Medicine, 75(11-12), 786-800.

DNA topoisomerase I : Customs officer at the border between DNA and RNA worlds? / Tazi, Jamal; Rossi, Ferdinand; Labourier, Emmanuel; Gallouzi, Imed; Brunel, Claude; Antoine, Etienne.

In: Journal of Molecular Medicine, Vol. 75, No. 11-12, 1997, p. 786-800.

Research output: Contribution to journalReview article

Tazi, J, Rossi, F, Labourier, E, Gallouzi, I, Brunel, C & Antoine, E 1997, 'DNA topoisomerase I: Customs officer at the border between DNA and RNA worlds?', Journal of Molecular Medicine, vol. 75, no. 11-12, pp. 786-800.
Tazi, Jamal ; Rossi, Ferdinand ; Labourier, Emmanuel ; Gallouzi, Imed ; Brunel, Claude ; Antoine, Etienne. / DNA topoisomerase I : Customs officer at the border between DNA and RNA worlds?. In: Journal of Molecular Medicine. 1997 ; Vol. 75, No. 11-12. pp. 786-800.
@article{6b6a0799b80b4d00bc84f92805bf3f26,
title = "DNA topoisomerase I: Customs officer at the border between DNA and RNA worlds?",
abstract = "DNA topoisomerase I is required for the normal development of multicellular organisms, probably because it plays a role in controlling gene activity, in addition to its function in relieving tortional stress during DNA replication and transcription. The discovery of DNA topoisomerase I as a specific kinase that phosphorylates serine-arginine rich (SR) splicing factors may provide new insights into their precise function in regulating gene expression. It is clear that the splicing factors phosphorylated by DNA topoisomerase I can modulate gene expression by changing the splicing pattern of structural genes. Studies of the splicing mechanism suggest that the phosphorylation of serine residues of SR proteins contribute to their activity. As this phosphorylation can be accomplished by several kinases, it remains to be determined whether phosphorylation by DNA topoisomerase I protein kinase is the limiting step in regulating this process. The availability of specific inhibitors of DNA topoisomerase I, structurally related to the alkaloid camptothecin, have made it possible to address this question experimentally. These inhibitors, which hold great promise as antineoplastic drugs, lead to specific inhibition of SR protein phosphorylation in cultured cells. This observation will hopefully lead to improved understanding of the mechanism by which these drugs act at cellular level.",
keywords = "Alternative splicing, DNA topoisomerase I, mRNA precursor, Nucleus, Protein kinase, Protein phosphorylation, Small nuclear Ribonucleoprotein, Splicing factors",
author = "Jamal Tazi and Ferdinand Rossi and Emmanuel Labourier and Imed Gallouzi and Claude Brunel and Etienne Antoine",
year = "1997",
language = "English",
volume = "75",
pages = "786--800",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "11-12",

}

TY - JOUR

T1 - DNA topoisomerase I

T2 - Customs officer at the border between DNA and RNA worlds?

AU - Tazi, Jamal

AU - Rossi, Ferdinand

AU - Labourier, Emmanuel

AU - Gallouzi, Imed

AU - Brunel, Claude

AU - Antoine, Etienne

PY - 1997

Y1 - 1997

N2 - DNA topoisomerase I is required for the normal development of multicellular organisms, probably because it plays a role in controlling gene activity, in addition to its function in relieving tortional stress during DNA replication and transcription. The discovery of DNA topoisomerase I as a specific kinase that phosphorylates serine-arginine rich (SR) splicing factors may provide new insights into their precise function in regulating gene expression. It is clear that the splicing factors phosphorylated by DNA topoisomerase I can modulate gene expression by changing the splicing pattern of structural genes. Studies of the splicing mechanism suggest that the phosphorylation of serine residues of SR proteins contribute to their activity. As this phosphorylation can be accomplished by several kinases, it remains to be determined whether phosphorylation by DNA topoisomerase I protein kinase is the limiting step in regulating this process. The availability of specific inhibitors of DNA topoisomerase I, structurally related to the alkaloid camptothecin, have made it possible to address this question experimentally. These inhibitors, which hold great promise as antineoplastic drugs, lead to specific inhibition of SR protein phosphorylation in cultured cells. This observation will hopefully lead to improved understanding of the mechanism by which these drugs act at cellular level.

AB - DNA topoisomerase I is required for the normal development of multicellular organisms, probably because it plays a role in controlling gene activity, in addition to its function in relieving tortional stress during DNA replication and transcription. The discovery of DNA topoisomerase I as a specific kinase that phosphorylates serine-arginine rich (SR) splicing factors may provide new insights into their precise function in regulating gene expression. It is clear that the splicing factors phosphorylated by DNA topoisomerase I can modulate gene expression by changing the splicing pattern of structural genes. Studies of the splicing mechanism suggest that the phosphorylation of serine residues of SR proteins contribute to their activity. As this phosphorylation can be accomplished by several kinases, it remains to be determined whether phosphorylation by DNA topoisomerase I protein kinase is the limiting step in regulating this process. The availability of specific inhibitors of DNA topoisomerase I, structurally related to the alkaloid camptothecin, have made it possible to address this question experimentally. These inhibitors, which hold great promise as antineoplastic drugs, lead to specific inhibition of SR protein phosphorylation in cultured cells. This observation will hopefully lead to improved understanding of the mechanism by which these drugs act at cellular level.

KW - Alternative splicing

KW - DNA topoisomerase I

KW - mRNA precursor

KW - Nucleus

KW - Protein kinase

KW - Protein phosphorylation

KW - Small nuclear Ribonucleoprotein

KW - Splicing factors

UR - http://www.scopus.com/inward/record.url?scp=0030828196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030828196&partnerID=8YFLogxK

M3 - Review article

VL - 75

SP - 786

EP - 800

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 11-12

ER -